[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370288-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370288-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","timp4-serves-as-a-novel-potential-prognostic-biomarker-for-oral-squamous-cell-carcinoma","TIMP4 serves as a novel potential prognostic biomarker for oral squamous cell carcinoma","","Abnormal expression of tissue inhibitor of metalloproteinase 4 (TIMP4) has been linked to multiple cancers, yet its function in oral squamous cell carcinoma (OSCC) is unclear. This study characterized TIMP4 expression in tumor and adjacent tissues from OSCC patients using immunohistochemistry and positive cell counting, and further validated findings with TCGA-HNSCC data. Kaplan-Meier survival analysis, TIMER immune-infiltration assessment, and pathway computations were applied. Results showed TIMP4 decreased in OSCC/HNSCC and correlated with metastasis, immune suppression, HPV positivity, and advanced staging, indicating poor prognosis. Further work is needed to define TIMP4 therapeutic potential.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/timp4-serves-as-a-novel-potential-prognostic-biomarker-for-oral-squamous-cell-carcinoma/370288/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/timp4-serves-as-a-novel-potential-prognostic-biomarker-for-oral-squamous-cell-carcinoma/370288.png","ImageObject",300,407,{"name":42,"@type":43},"Liam","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",17,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why was TIMP4 investigated in oral squamous cell carcinoma (OSCC)?","Question",{"text":63,"@type":64},"TIMP4’s abnormal expression relates to several cancers, but its specific role in OSCC remains unclear. The study aimed to clarify its expression pattern and prognostic significance in OSCC.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were TIMP4 expression levels measured in the study?",{"text":68,"@type":64},"Tumor and adjacent non-tumor tissues from OSCC patients were analyzed using immunohistochemistry (IHC) with positive cell counting. The TCGA-HNSCC dataset was also used to further assess TIMP4 expression.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the survival and immune infiltration analyses show?",{"text":72,"@type":64},"Kaplan-Meier analysis evaluated survival and prognosis, while TIMER was used to examine how TIMP4 expression correlated with tumor immune infiltration. The findings indicate TIMP4 decrease is linked to poor prognosis and immune suppression.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370288,1790632479,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":113,"preview_page_count":33,"preview_urls":146},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nTIMP4 serves as a novel potential prognostic biomarker for oralsquamous cell carcinoma  \nLian Zhou1,6, Changlin Tang2,6, Renjie Shuai3, Binxin Chen4, XinyanYang5, Yungang He1􀀍 & Jian Wu1􀀍  \nThe abnormal expression of tissue inhibitor of metalloproteinase 4 (TIMP4) is associated with multiple human cancers. However, the role ofTIMP4 in oral squamous cell carcinoma (OSCC) remains elusive. Therefore, this study explored the expression profile and prognosis ofTIMP4 in OSCC. Tumor and adjacent non-tumor tissues were collected from OSCC patients, and protein expression ofTIMP4 was detected through immunohistochemistry (IHC) and positive cell counting. Additionally, The Cancer Genome Atlas-Head and Neck Squamous Cell Carcinoma (TCGA-HNSCC) dataset was used to analyze TIMP4 expression further to determine its relationship with HNSCC clinical characteristics. Kaplan-Meier analysis was used to evaluate survival and prognosis. Meanwhile, the Tumor Immune Estimation Resource (TIMER) database was employed to assess the correlation between TIMP4 expression and tumor immune infiltration. Computational tools were also applied to investigate the involvement ofTIMP4 in cancer pathways. Results showed that TIMP4 was decreased inOSCC and HNSCC compared with normal tissues. The decrease inTIMP4 was associated with cancer metastasis, immune suppression and HPV positive, clinical staging. Overall, these findings demonstrate that TIMP4 is significantly reduced in OSCC and HNSCC, and associated with a poor prognosis. Additional investigations are warranted to fully understand the therapeutic potential ofTIMP4 in OSCC.  \nKeywords Oral squamous cell carcinoma, Tissue inhibitor of metalloproteinase 4 (TIMP4), Prognosis, Biomarker, Immune infiltration  \nAccording to the recent World Health Organization data, head and neck squamous cell carcinoma (HNSCC) is the sixth most common cause of cancer-related deaths worldwide and has become an important global health issue1,2. Oral squamous cell carcinoma (OSCC) is the most common type of HNSCC, accounting for about 70% of all HNSCCs3,4. Approximately 550,000 new cases and 260,000 deaths from OSCC are reported annually worldwide5,6, showing a high-incidence trend. With changes in social lifestyle and habits, unhealthy biological factors such as smoking, alcohol consumption, betel nut chewing, long-term night shifts, and mental anxiety and tension, the incidence of OSCC is significantly increasing in recent years, especially in the younger population7. Therefore, improving the clinical treatment effect of OSCC and enhancing the patient’s survival status with OSCC is paramount.  \nAccording to the recent clinical guidelines, the current treatment for OSCC involves a multidisciplinary treatment model that includes surgery, chemotherapy, radiotherapy, targeted therapy, and immunotherapy8,9, etc. However, even with this comprehensive approach, the improvement in clinical outcomes remains insignificant, with the 5-year survival rate for OSCC patients being about 60%10. Cervical lymph node and distant metastases are the main factors threatening patient survival11. Current techniques and research cannot meet the clinical needs ofOSCC. Thus, filling the gaps in mechanism analysis, genetic research, and treatment plans is urgent.  \nTissue inhibitors of metalloproteinases (TIMPs) form a specialized protein family that specifically curbs the enzymatic activity of matrix metalloproteinases (MMPs). This family consists of four distinct members: TIMP1, TIMP2, TIMP3, and TIMP412. Through their binding to MMPs, TIMPs effectively prevent the breakdown of the extracellular matrix (ECM), thus playing an indispensable role in a wide array of physiological processes such as tissue remodeling, cell proliferation, migration, and apoptosis13. Currently, TIMP1, TIMP2, and TIMP3 have  \n1Head and Neck Surgery, Chongqing University Cancer Hospital, No.181 Hanyu Ro","cbCaitGOckATHN2Q","https://ap.wps.com/l/cbCaitGOckATHN2Q","pdf",2854518,12,"English","# Background\n## Epidemiology and clinical challenge in OSCC\n## Current treatment landscape and unmet needs\n# TIMP4 and study rationale\n## TIMPs and TIMP4 in cancer\n# Methods\n## Patient tissue collection and immunohistochemistry\n## TCGA-HNSCC expression analysis\n## Survival analysis\n## Immune infiltration correlation\n## Pathway analysis\n# Results\n## TIMP4 downregulation in OSCC/HNSCC\n## Associations with metastasis, immunity, HPV and staging\n# Conclusion\n## Prognostic value and need for further investigation","[{\"question\":\"Why was TIMP4 investigated in oral squamous cell carcinoma (OSCC)?\",\"answer\":\"TIMP4’s abnormal expression relates to several cancers, but its specific role in OSCC remains unclear. The study aimed to clarify its expression pattern and prognostic significance in OSCC.\"},{\"question\":\"How were TIMP4 expression levels measured in the study?\",\"answer\":\"Tumor and adjacent non-tumor tissues from OSCC patients were analyzed using immunohistochemistry (IHC) with positive cell counting. The TCGA-HNSCC dataset was also used to further assess TIMP4 expression.\"},{\"question\":\"What did the survival and immune infiltration analyses show?\",\"answer\":\"Kaplan-Meier analysis evaluated survival and prognosis, while TIMER was used to examine how TIMP4 expression correlated with tumor immune infiltration. The findings indicate TIMP4 decrease is linked to poor prognosis and immune suppression.\"}]","TIMP4 serves as a novel potential prognostic biomarker for oral squamous cell carcinoma | PDF",1790187782,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/332889367f37e417e5879164a53d5e3d.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a7a7b14f3e82395dd564dd3b654ad16d.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9bc160b3b53eb8fd14f220219425bc57.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e53d50d4625f44cc2a1e58da13896967.webp",980,1287]